1022094-33-2Relevant academic research and scientific papers
A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
Li, Fangfei,Lu, Jun,Liu, Jin,Liang, Chao,Wang, Maolin,Wang, Luyao,Li, Defang,Yao, Houzong,Zhang, Qiulong,Wen, Jia,Zhang, Zong-Kang,Li, Jie,Lv, Quanxia,He, Xiaojuan,Guo, Baosheng,Guan, Daogang,Yu, Yuanyuan,Dang, Lei,Wu, Xiaohao,Li, Yongshu,Chen, Guofen,Jiang, Feng,Sun, Shiguo,Zhang, Bao-Ting,Lu, Aiping,Zhang, Ge
, (2017)
Paclitaxel (PTX) is among the most commonly used first-line drugs for cancer chemotherapy. However, its poor water solubility and indiscriminate distribution in normal tissues remain clinical challenges. Here we design and synthesize a highly water-solubl
BIOLOGICAL MATERIALS AND USES THEREOF
-
Page/Page column 80, (2016/06/06)
The invention provides compounds comprising a therapeutic agent coupled to a carrier molecule, with a minimum coupling ratio of 5: 1; wherein the carrier molecule is (i) an antibody fragment or derivative thereof or (ii) an antibody mimetic or derivative thereof; and wherein the therapeutic agents are coupled onto a lysine amino acid residue; and further wherein the therapeutic agent is not a photosensitising agent. There is also provided uses, methods relating to such compounds, as well as processes for their manufacture.
A cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapy
Yoneda, Yoshiyuki,Steiniger, Sebastian C.J.,Capkova, Katerina,Mee, Jenny M.,Liu, Ying,Kaufmann, Gunnar F.,Janda, Kim D.
, p. 1632 - 1636 (2008/12/21)
Tumor targeting peptides are promising vehicles for site-directed cancer therapy. Pep42, a cyclic 13-mer oligopeptide that specifically binds to glucose-regulated protein 78 (GRP78) and internalized into cancer cells, represents an excellent vehicle for tumor cell-specific chemotherapy. Here, we report the synthesis and evaluation of Pep42-prodrug conjugates that contain a cathepsin B-cleavable linker, resulting in the traceless release of drug inside the cancer cells.
